Medical scientific research executed in more than one institution in the Netherlands simultaneously is called a multicentre research. Based on the Research Declaration (or Site suitability Declaration), the central Ethics Committee grants approval for every participating centre. The CCMO External Review Directive describes the general procedure. After the central approval, the Board of Directors of the other institutions will send a final approval letter.
Please note that for clinical trials with medicinal products a Site Suitability Declaration is mandatory and no final approval by the Board of Directors will be issued. The signature on the clinical trial agreement can be seen as final approval by the Board of Directors. See also: ccmo.nl
